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Catalase deficiency renders remnant kidneys more susceptible
to oxidant tissue injury and renal fibrosis in mice.
Background. Catalase is one of the important antioxidant
enzymes regulating the levels of intracellular hydrogen perox-
ide and hydroxyl radical. The effect of catalase deficiency on
progressive renal fibrosis has not been fully elucidated.
Methods. Homozygous acatalasemic mutant mice (C3H/
AnLCsbCsb) and control wild-type mice (C3H/AnLCsaCsa)
were subjected to 5/6 nephrectomy. The functional and morpho-
logical alterations of the remnant kidneys, including tubuloin-
terstitial fibrosis, epithelial to mesenchymal transition (EMT),
peroxidation, antioxidant enzyme activity, and gene expression
of EMT-related molecules were compared between the two
groups at 6, 12, and 18 weeks after 5/6 nephrectomy.
Results. The 5/6 nephrectomy resulted in albuminuria, de-
creased renal function, and tubulointerstitial fibrosis with accu-
mulation of type I and type IV collagens in the remnant kidneys
of both mouse groups. However, the degree of these changes
was significantly higher in acatalasemic mice after 5/6 nephrec-
tomy as compared with wild-type mice until week 18. EMT, a
crucial phenotypic alteration of tubular epithelial cells, was ob-
served in acatalasemic mice by electron microscopy and was
associated with upregulation of EMT-related a-smooth mus-
cle actin (a-SMA), transforming growth factor-b1 (TGF-b1),
connective tissue growth factor (CTGF), and fibroblast spe-
cific protein-1 (FSP-1) gene expression. Significant increases
in the tubulointerstitial deposition of lipid peroxidation prod-
ucts, including 4-hydroxy-2-nonenal and urinary excretion of 8-
hydroxy-2′- deoxyguanosine were observed in the acatalasemic
mice after 5/6 nephrectomy as compared with the wild-type
mice. Glomerular sclerosis developed after tubulointerstitial in-
jury in acatalasemic mice. The level of catalase activity remained
low in the remnant kidneys of acatalasemic mice until week 18
without compensatory up-regulation of glutathione peroxidase
or superoxide dismutase (SOD) activity. Finally, supplementa-
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tion of a SOD mimetic tempol did not prevent peroxidation and
tubulointerstitial fibrosis in the acatalasemic remnant kidneys.
Conclusion. These findings indicate that acatalasemia exacer-
bates renal oxidant tissue injury and sensitizes remnant kidneys
to EMT and progressive renal fibrosis. This study suggests a cen-
tral role for catalase in the defense against oxidant-mediated
renal fibrosis.
Oxidant-mediated tissue injury plays an important role
in the development and progression of major organ fibro-
sis, including the heart, liver [1], and pancreas [2]. The
degree of oxidative stress and the severity of subsequent
organ fibrosis have been postulated to depend on the im-
balance between excess production of reactive oxygen
species (ROS) and the antioxidant defense system within
the tissue [3]. These antioxidants include the enzymes
superoxide dismutase (SOD), catalase, and glutathione
peroxidase, which detoxify ROS. Overexpression of glu-
tathione peroxidase has been shown to inhibit oxidant
tissue injury such as cardiac fibrosis [4]. The kidney has a
high rate of oxidative metabolism as evidenced by the fact
that the intact kidneys which represent less than 1% of
the total body weight, nevertheless account for approx-
imately 10% of the total oxygen consumption, putting
the renal tubulointerstitium at continuous risk of oxidant
tissue injury.
Catalase is a major enzyme that catalyzes the decom-
position of hydrogen peroxide (H2O2) and plays a role
in cellular antioxidant defense mechanisms [5]. The en-
zyme is localized in the matrix of peroxisomes in mam-
malian cells and is involved in two different types of en-
zymatic reactions: the catalatic mode (2H2O2 → O2 +
2 H2O) and the peroxidatic mode (H2O2 + AH2 →
A + 2 H2O) [6]. Catalase thus limits the accumulation
of H2O2, which is generated by various oxidases in tissue
and serves as a substrate for the Fenton reaction to gener-
ate the highly injurious hydroxyl radical. Genetic defects
of catalase were first documented by Takahara [7] and
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Ogata [8] in Japanese patients who exhibited a deficiency
of blood catalase enzyme activity (acatalasemia). Short-
term clinical manifestations in acatalasemic patients ap-
pear predominantly in the mouth after exposure to H2O2
or infection with peroxide-generating bacteria such as
streptococci and pneumococci, and the related activity
of phagocytic cells at inflamed sites.
Subsequently, an acatalasemic mouse strain (Csb) was
established by Feinstein, Suter, and Jaroslow [9] from
the progeny of x-ray–irradiated mice. The tissues of
acatalasemic mice express normal catalase mRNA lev-
els compared with those of wild-type mice, suggesting the
mutation does not act at the level of gene transcription or
mRNA stability, but rather at the level of mRNA transla-
tion and/or protein turnover [10]. The mutation has been
mapped to the mouse catalase structural gene on chro-
mosome 2 (Cat or Cas1) and is expressed by modification
of the enzyme active site but not of the antigenic site [9].
Recently, a new line of catalase null mice has been gen-
erated by a gene targeting technique [11]. Unexpectedly,
homozygous Cat knockout mice are not more vulnera-
ble to hypoxia-induced lung injury, nor do their lenses
exhibit any increased susceptibility to oxidant-mediated
injury. However, they are susceptible to brain injury fol-
lowing physical trauma causing a significant decrease in
mitochondrial electron transfer [11], indicating a differ-
ential pattern of oxidant sensitivity in the types of tissue
from Cat mutant mice. Since patients with acatalasemia
have residual catalase activity in tissues, the mouse phe-
notype of complete Cat gene knockout may not reflect
the human acatalasemic conditions.
Deterioration of renal function is largely determined
by the degree of tubulointerstitial changes rather than
by the extent of histologic changes in the glomeruli in
many forms of renal disease [12]. Creatinine clearance
or the glomerular filtration rate (GFR) correlates better
with indices of tubulointerstitial damage than with those
of glomerular injury [13]. Indeed, damage to the tubu-
lointerstitium causes changes in the extracellular matrix
(ECM) and leads to a remodeling of the tubulointersti-
tial structure [14]. The ECM of the tubulointerstitium
in progressive renal disease increases, which eventually
leads to irreversible fibrosis of the kidney. Renal fibrosis
is characterized by the loss of renal tubules and intersti-
tial capillaries as well as the accumulation of ECM pro-
teins, such as collagen types I, II, IV, V, VII, fibronectin,
and laminin [12]. Increased myofibroblasts and inflamma-
tory cells have been identified as sources of the accumu-
lated ECM in renal fibrosis [15]. However, the pathogenic
mechanisms of renal interstitial ECM accumulation and
fibrosis have not been fully elucidated yet.
Epithelial to mesenchymal transition (EMT) is a key
phenotypic alteration of renal tubular epithelial cells
(TECs) transdifferentiated into fibroblasts. Pioneering
studies by Strutz et al [16] indicated that TECs could
express fibroblast-specific markers in renal diseases, sug-
gesting a central role of EMT in renal tubulointerstitial fi-
brosis [16]. Subsequently, a growing body of evidence has
indicated that a large proportion of up to one third of in-
terstitial fibroblasts originate from TECs via EMT in dis-
ease states [17]. Both the pro- and antifibrotic molecules
are believed to play roles in the regulation of the fibro-
genic process, including EMT. In particular, transform-
ing growth factor-b1 (TGF-b1) [18] and connective tissue
growth factor (CTGF) [19] are considered to promote fi-
brosis; in contrast, bone morphogenic protein 7 (BMP-7)
[17, 20] and hepatocyte growth factor (HGF) [21] coun-
teract profibrotic responses. However, other intracellular
mediators may play important roles as well. Indeed, a re-
cent report suggests that the increase in ROS by catalase
deficiency may be involved in renal fibrosis after unilat-
eral ureteral obstruction (UUO) [22]. In that report, how-
ever, the role of ROS in mediating tubular EMT and the
expression of EMT-related genes was not investigated.
The role of ROS in mediating tubular EMT and subse-
quent renal fibrosis is currently largely unknown.
In the present study, we hypothesized that a defect in
the antioxidant system in the form of catalase deficiency
would enhance oxidant tissue injury, renal tubular EMT,
and interstitial fibrosis, eventually leading to the loss of
renal function. This hypothesis was tested by inducing
5/6 nephrectomy, which is a well-established model of
progressive renal fibrosis, into acatalasemic mice. More-
over, the effect of tempol, a membrane-permeable SOD
mimetic, on oxidant-mediated renal fibrosis in acata-
lasemia was also investigated. The data presented here
suggest that acatalasemia promotes renal fibrosis via the
acceleration of tubular EMT in association with an ele-
vation of EMT-related genes.
METHODS
Experimental animal protocol
Male wild-type mice (C3H/AnLCsaCsa) and male ho-
mozygous acatalasemic mutant mice (C3H/AnLCsbCsb)
were used at the age of 7 to 10 weeks old. Animals
were housed in a group of five and fed standard chow
and water ad libitum. Renal ablation was induced by
the pole resection protocol with the mice under pen-
tobarbital anesthesia as described previously [23, 24].
Mice were divided into subgroups (N = 10/group). Body
weight was measured every 6 weeks until 18 weeks. Arte-
rial blood pressure was measured every 6 weeks using a
programmable sphygmomanometer (BP-98A) (Softron,
Tokyo, Japan) by the tail-cuff method as described pre-
viously [24, 25]. Mean blood pressure was calculated as
(systolic pressure + 2 × diastolic pressure)/3. Twenty-
four hour urine samples were collected in metabolic
cages. Mice that were operated on were sacrificed un-
der pentobarbital anesthesia 0 (N = 10), 6 (N = 10), 12
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(N = 10), and 18 (N = 10) weeks after 5/6 nephrectomy.
Sham operation, in which mice had their kidneys manip-
ulated but not nephrectomized, was also performed on
both wild-type and acatalasemic mice (N = 10 in each
time point) [23, 24]. Immediately before death, blood
samples were drawn from the retro-orbital sinus. Three
acatalasemic mice but none of wild-type mice died af-
ter 5/6 nephrectomy during the experimental period. In
tempol-treated groups, mice received continuous infu-
sion of tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-
N-oxyl, 100 mg/kg body weight/day) (Sigma Chemical
Co., St. Louis, MO, USA) via subcutaneous osmotic
minipumps (Alzet model 2004) (Alza Corp., Palo Alto,
CA, USA) over a 8-week period from 5 to 12 weeks af-
ter 5/6 nephrectomy. The minipumps were replaced with
new ones at 4 weeks after the first implantation. The ex-
perimental protocol was approved by the Ethics Review
Committees for Animal Experimentation of Okayama
University Graduate School.
Blood and urine examination
Serum creatinine, blood urea nitrogen (BUN), thiobar-
bituric acid reactive substance (TBARS), urinary creati-
nine levels, and urinary albumin excretion were measured
as described previously [22]. Creatinine clearance was
calculated in individual mice as lL/min/g body weight.
As a marker for oxidative DNA damage, we measured
the urinary excretion of 8-hydroxy-2′-deoxyguanosine
(8-OHdG) in a 24-hour urine collection by enzyme-
linked immunosorbent assay (ELISA) using the 8-OHdG
ELISA Kit (Japan Institute for the Control of Aging,
Shizuoka, Japan) as recommended by the manufacturer
[26]. Absorbance was measured at 540 nm using a mi-
croplate reader (model 550) (Bio-Rad, Hercules, CA,
USA).
Reagents and antibodies
Chemicals and reagents of analytic grade were pur-
chased from Sigma Chemical Co. or Wako Pure Chem-
ical Ind. (Osaka, Japan) unless stated. meso-Tetrakis
(1-methyl-4-pyridyl)-porphyrin was purchased from Do-
jindo Labs (Kumamoto, Japan). The following primary
antibodies were used for immunohistochemistry: mouse
monoclonal antibodies to 4-hydroxy-2-nonenal (4-HNE)
[26] or 4-hydroxy-2-hexenal (4-HHE) were obtained
from Nof Life Science (Tokyo, Japan), biotinylated
Arachis hypogaea peanut agglutinin from Vector Labo-
ratories, Inc. (Burlingame, CA, USA), rabbit polyclonal
antibodies against type I collagen and type IV collagens
from Chemicon International Inc. (Temecula, CA, USA).
Light and electron microscopic studies
Remnant or control kidneys were removed, fixed in
10% buffered formalin, and embedded in paraffin. Paraf-
fin sections (3 lm thick) were stained with periodic
acid-Schiff (PAS), Masson trichrome, and Azan-Mallory
staining [22–24, 27]. Two independent observers with
no prior knowledge of the experimental design evalu-
ated each tissue section by an Olympus light microscope
(Olympus, Tokyo, Japan) with high-resolution digital
camera systems (Penguin 600CL) (Pixera Co., Los Gatos,
CA, USA). The diameter of glomeruli, spanning from
the vascular pole to the opposite Bowman’s capsule, was
measured using a Microanalyzer program (version 1.1)
(Japan Poladigital Co., Tokyo, Japan). Glomerular scle-
rosis was graded as follows: 0, none; +1, sclerotic changes
in <25% of the glomerulus; +2, from 25% to 50%; and
+3, >50% [23, 24]. The mean score per glomerulus in
each kidney was determined as the sclerosis index. More
than 30 glomerular cross sections were examined by two
investigators and averaged. The observers scored with a
semiquantitative scale designed to evaluate the degree of
tubulointerstitial injuries, including tubular atrophy and
interstitial fibrosis in Masson trichrome stain [22]. The
tubulointerstitial fibrosis score ranging from 0 to 4 was
determined as follows: 0, normal kidney; 1, mild change;
2, moderate change; 3, severe change; and 4, whole tissue
was injured. The scores were determined in each section
selected at random and more than 20 fields were exam-
ined under ×100 magnification. Electron microscopy was
performed in the mouse kidney specimens as described
previously [22, 28]. In brief, tissue blocks of kidney sec-
tions were immersed in 2.5% glutaraldehyde for 2 hours
at 4◦C and postfixed with 1% osmium tetroxide. The
blocks were then processed for routine dehydration, epon
embedding, and thin sectioning, and examined with an
electron microscope (Hitachi, Tokyo, Japan). The quan-
titative analysis was performed to count the number of
actin bundle–positive TECs and total TECs in each sam-
ple by electron microscopy. The mean percentage of actin
bundle–positive TECs per total TECs was determined.
Immunohistochemical studies
Deposition of lipid peroxidation products in renal
tubulointerstitium were examined by immunoperoxidase
staining as described previously [22]. Briefly, formalin-
fixed, paraffin-embedded sections were deparaffinized,
and endogenous peroxidase was inactivated with 0.3%
H2O2. Unfixed cryostat sections (4 lm thick) were pre-
pared for the staining of a-smooth muscle actin (a-SMA).
Sections were then washed in phosphate-buffered saline
(PBS) three times, 5 minutes each, preincubated in a
blocking solution (10% goat serum in PBS) for 30 min-
utes, washed in PBS three times, and then incubated for
1 hour at room temperature or overnight at 4◦C with
primary antibodies. Sections using control kidneys were
treated similarly but without addition of the primary an-
tibody. Each section was washed three times in PBS and
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Table 1. Primer sequences, product sizes, and conditions for real-time PCR analysis
Product GenBank Annealing Cycle
Sense primer Antisense primer size bp accession number temperature number
TGF-b1 5′-AACAACGCCATCTATGAG 5′-TATTCCGTCTCCTTGGTT 294 NM 011577 61 40
CTGF 5′-AAGACCTGTGGGATGGGC 5′-GTGCAGCCAGAAAGCTCA 191 BC006783 62 40
a-SMA 5′-GACAGGATGCAGAAGGAGAT 5′-TTAGAAGCATTTGCGGTG 198 BC064800 62 40
FSP-1 5′-CAGGCAAAGAGGGTGACAAG 5′-TGCAGGACAGGAAGACACAG 186 NM 011311 62 40
GAPDH 5′-TGAACGGGAAGCTCACTGG 5′-TCCACCACCCTGTTGCTGTA 307 NM 001001303 60 40
Abbreviations are: TGF-b1, transforming growth factor beta-1; CTGF, connective tissue growth factor; a-SMA, a-smooth muscle actin; FSP-1, fibroblast specific
protein-1; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
then incubated with the second antibody for 30 min-
utes. Biotinylated rabbit antimouse IgG (Nichirei Corp.,
Tokyo, Japan) (dilution 1:1000) was used as the second
antibody. After the sections were washed with PBS three
times, they were placed in peroxidase-labeled strepta-
vidin (Nichirei Corp.). They were placed in diaminoben-
zidine/H2O2 solution, counterstained with hematoxylin,
dehydrated, and enclosed in synthetic resin. Peroxidation
products were determined on the basis of the intensity
and distribution of deposition in the tubulointerstitium:
0, none or trace staining; 1, mild; 2, moderate; and 3, se-
vere staining. The score was determined in 20 randomly
selected nonoverlapping ×200 fields in each section of
the individual mouse renal cortex. The average number
of score from ten separate animals was calculated.
Indirect immunofluorescence was performed as de-
scribed previously [22, 24, 27]. Briefly, surgically removed
kidney specimens were immediately snap-frozen and un-
fixed cryostat sections (4 lm thick) were prepared. The
sections were washed in PBS three times, 5 minutes each,
and then incubated with rabbit polyclonal antibodies
against type I, type III, or type IV collagen (dilution 1:50)
as the primary antibody in PBS for 1 hour at room tem-
perature. Each section was washed three times in PBS
and incubated with fluorescein isothiocyanate (FITC)-
conjugated goat antirabbit IgG (Zymed Laboratories,
Inc., San Francisco, CA, USA) (dilution 1:100) as the
second antibody in PBS for 30 minutes. After the sec-
tion was washed with PBS three times, it was mounted
with fluoromount-G. Deposition of type I, III, or IV col-
lagens in the tubulointerstitium of renal cortex was as-
sessed semiquantitatively by fluorescence microscopy as
described previously [22, 27]. The collagen deposition
score was determined on the basis of the intensity and
distribution of each collagen in the tubulointerstitium: 0,
none; 1, trace; 2, mild; 3, moderate; and 4, severe stain-
ing. The score was determined in each section selected
at random and more than 20 fields were examined under
×100 magnification.
Extraction of total RNA and quantitative real-time
polymerase chain reaction (PCR) analysis
Total RNA was extracted from the whole kidney by us-
ing an RNeasy Midi Kit using the instructions provided
by the manufacturer (Qiagen, Valencia, CA, USA) and
quantified by measuring absorbance at 260 nm and stored
at −80◦C until assay [24, 27]. Two micrograms of total
RNA from each sample was used for reverse transcrip-
tion (RT) using a GeneAmp RNA PCR kit (Applied
Biosystems, Foster City, CA, USA) with random hex-
amer (2.5 lmol/L), murine leukemia virus reverse tran-
scriptase (50 U), and deoxyribonucleoside triphosphate
(1 mmol/L) at 42◦C for 15 minutes, 99◦C for 5 minutes,
and then 5◦C for 5 minutes [29]. For the quantification
of mRNA levels of EMT-related genes, real-time PCR
was performed using LightCycler-FastStart DNA master
SYBR Green I system (Roche Diagnostics, Mannheim,
Germany). Oligonucleotides used for real-time PCR
to quantify the amounts of TGF-b1, CTGF [30], a-
SMA [31], fibroblast specific protein-1 (FSP-1) (S100
calcium binding protein A4) [32], and glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) were custom-
ordered from Nihon Gene Research Lab Inc. (Sendai,
Miyagi, Japan). Sequences of the mouse primer pairs
and the original clones are listed in Table 1. After RT,
cDNA was diluted 1:10 with autoclaved deionized wa-
ter and 5 lL of the diluted cDNA was added to the
Lightcycler-Mastermix (0.5 lmol/L of specific primer,
3 mmol/L MgCl2 and 2 lL Master SYBR Green) (Roche
Diagnostics). This reaction mixture was filled up with wa-
ter to a final volume of 20 lL. PCR reactions were car-
ried out in a real-time PCR cycler (Lightcycler) (Roche
Diagnostics) and analyzed using Roche Molecular Bio-
chemicals Lightcycler Software version 3.5 (Roche Di-
agnostics). The program was optimized and performed
finally as denaturation at 95◦C for 10 minutes followed
by 40 cycles of amplification (Table 1). The temperature
ramp rate was 20◦C per second. At the end of each ex-
tension step, the fluorescence of each sample was mea-
sured to allow the quantification of the PCR product.
After completion of the PCR, the melting curve of the
product was measured by temperature gradient from 60
to 95◦C at 0.2◦C per second with continuous fluores-
cence monitoring to produce a melting profile of the
primers. The amount of PCR products was normalized
with GAPDH to determine the relative expression ratios
for each mRNA in relation to GAPDH mRNA. RT-PCR
experiments were repeated twice under identical condi-
tions to verify the results.
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Table 2. Metabolic data
Group 0 week 6 weeks 12 weeks 18 weeks
Body weight g
Wild-type 5/6 nephrectomy 27.4 ± 0.4 31.2 ± 0.7c 32.7 ± 0.6b 37.0 ± 1.1a
Acatalasemic 5/6 nephrectomy 26.2 ± 0.5 29.9 ± 0.9d 31.4 ± 1.5c 30.3 ± 1.7d
Relative kidney weight mg/g body weight
Wild-type 5/6 nephrectomy 9.0 ± 0.4 6.3 ± 0.4c 6.7 ± 0.5c 6.6 ± 0.3c
Acatalasemic 5/6 nephrectomy 9.4 ± 0.3 6.6 ± 0.2b 6.1 ± 0.5b,d 6.4 ± 0.4b
Mean blood pressure mm Hg
Wild-type 5/6 nephrectomy 77.4 ± 2.4 81.7 ± 2.3 81.0 ± 2.8 78.8 ± 3.0
Acatalasemic 5/6 nephrectomy 76.3 ± 3.6 81.3 ± 2.6 87.1 ± 3.1 82.8 ± 4.1
Values are means ± SE (g) of 8 to 10 animals in each group.
aP < 0.001; bP < 0.01; cP < 0.05 vs. 0 week in the same group; dP < 0.05 vs. wild-type 5/6 nephrectomy group at the same time point.
Renal catalase, glutathione peroxidase, and SOD activity
When kidneys were harvested, each kidney was decap-
sulated, washed with saline, bisected coronally, blotted
dry on gauze, and weighed as described previously [22,
24, 27]. The whole kidney weight was expressed as a per-
centage of body weight determined at the time the mice
were sacrificed. Dried kidney weight was not determined.
After harvesting obstructed or contralateral kidney from
either wild or acatalasemic mice, samples were stored in –
80◦C freezer until assay. Catalase activity was determined
by measuring the removal rate of 70 lmol/L H2O2 based
on the method of Sunami et al [22] and Masuoka et al [33,
34]. Samples, including renal cortex, were homogenized
with a Teflon homogenizer in homogenization buffer
[0.1 mol/L potassium phosphate buffer (PPB) (pH 7.2)
containing 1 mmol/L ethylenediaminetetraacetic acid
(EDTA), and 1% Triton X-100]. The samples were cen-
trifuged for 30 minutes (11,000 × g) at 4◦C. The super-
natant was removed and diluted with 0.1 mol/L PPB to
make 0.2% homogenate. Then, 0.2 mL of 3.5 mmol/L
H2O2 was added and after 0, 30, and 60 seconds, 2 mL
of the reaction mixture (containing less than 140 nmol of
H2O2) was taken out and put into the test tubes con-
taining 2 mL of the reagent solution [consisted of 10
volumes of 0.2 mmol/L meso-tetrakis(4-methylpyridyl)-
porphinatoiron (III) pentachloride solution, 10 volumes
of 41.2 mm N,N-dimethylaniline in 0.2 mol/L hy-
drochloric acid, 10 volumes of 8.56 mmol/L 3-methyl-
2-benzothiazolinone hydrazone solution in 0.2 mol/L
hydrochloric acid and 1 volume of 20 mmol/L EDTA
solution]. The mixture was incubated at 25◦C for 1 h, and
then the absorbance at 590 nm was measured.
Glutathione peroxidase activity was determined by the
method as described previously [35] with some modifi-
cation. The assay is an indirect measure of the activity
of cellular glutathione peroxidase. Oxidized glutathione
is recycled to its reduced form by glutathione reduc-
tase. The oxidation of nicotinamide adenine dinucleotide
phosphate (NADPH) resulting NADP+ is accompanied
by a decrease in absorbance at 340 nm so that glu-
tathione peroxidase activity can be monitored. To assay
glutathione peroxidase, tissue homogenate was added to
a solution containing glutathione, glutathione reductase
and NADPH. The enzyme reaction was started by adding
tert-butyl hydroperoxide as a substrate and the 340 nm
absorbance was recorded every 5 seconds for 1 minute.
The rate of decrease in the 340 nm absorbance was di-
rectly proportionate to glutathione peroxidase activity in
the sample. The activity of SOD was measured as de-
scribed by Sutherland and Learmonth [36] using an SOD
assay kit (Trevigen, Gaithersburg, MD, USA) [37]. This
method is based on the inhibition of the reduction of nitro
blue tetrazolium by SOD. Superoxide ions convert nitro
blue tetrazolium into blue formazan. Blue formazan ab-
sorbs light at 550 nm. SOD reduces the superoxide ion
concentration and thereby lowers blue formazan forma-
tion. The extent of reduction in the appearance of blue
formazan reflects the amount of SOD activity in a sample.
Statistical analyses
Data, shown as mean ± SEM, were analyzed by the
Mann-Whitney U test or one-way analysis of variance
(ANOVA) using the StatView program (Hulinks, Tokyo,
Japan). P values < 0.05 were accepted as statistically sig-
nificant.
RESULTS
Changes in body weight, kidney weight, and arterial blood
pressure in the mouse remnant kidney model
The remnant kidney model has been extensively stud-
ied in many different rat strains. In contrast, mice have
generally been resistant to this model, particularly in ani-
mals of the C57BL/6 background [38]. Therefore, we first
tried to characterize this model in our mouse strains. Male
acatalasemic mice were found on observation to grow
normally and were apparently healthy up to 1 year of
age. Female acatalasemic mice were as fertile as wild-
type mice. The morphology of major organs, including
the heart, lung, liver, and kidney, appeared normal upon
histologic examination at the level of light microscopy.
Body weight and relative kidney weight were similar be-
tween both groups at the start of the experiment (Table 2).
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Fig. 1. Changes in renal function and urinary albumin excretion in wild-type () and acatalasemic mice (). (A) Serum creatinine significantly
increased in both groups at 6 weeks after 5/6 nephrectomy (5/6Nx). The elevation of serum creatinine in acatalasemic mice is remarkable at 12 and
18 weeks after 5/6 nephrectomy as compared to that in wild-type mice. (B) Creatinine clearance markedly decreased in both groups at 6 weeks
after 5/6 nephrectomy. In acatalasemic mice, the decrease in creatinine clearance was significantly more than that in wild-type mice at 12 and 18
weeks after 5/6 nephrectomy. (C) Daily urinary albumin to creatinine excretion ratio. The 5/6 nephrectomy significantly increased urinary albumin
exrection in acatalasemic mice at 6 weeks but not in wild-type mice. Urinary albumin excretion remarkably increased in acatalasemic group after
12 weeks. Each column consists of means ± SE (N = 7 to 10 animals/group). ∗P < 0.05; ∗∗P < 0.01 vs. wild-type 5/6 nephrectomy mice at the same
time point; #P < 0.05; ##P < 0.01 vs. sham at 0 week in the same group.
A significant increase in body weight was observed at 6,
12, and 18 weeks in the wild-type 5/6 nephrectomy mice,
while an increase in body weight of the acatalasemic mice
after 5/6 nephrectomy was not observed at time points
later than 12 weeks. The decrease in the kidney weight
to body weight ratio was observed in both groups and
it was significant in acatalasemic 5/6 nephrectomy at 12
weeks as compared to that in wild-type 5/6 nephrectomy.
Arterial blood pressure in acatalasemic 5/6 nephrectomy
slightly increased at 12 weeks, without a significant dif-
ference from that in acatalasemic control or wild-type 5/6
nephrectomy at the same time point (Table 2).
Increase in albuminuria and decrease in renal function
are significantly accelerated in acatalasemic mice after
5/6 nephrectomy
To evaluate the effect of acatalasemia on 5/6
nephrectomy–induced alteration of biologic functions,
we measured parameters of renal function (serum cre-
atinine and creatinine clearance) and daily urinary al-
bumin excretion (Fig. 1). The basal levels of serum cre-
atinine, creatinine clearance, urinary albumin excretion
were not significantly different between the wild-type and
acatalasemic mice. In both groups, significant increases
in serum creatinine and decreases in creatinine clear-
ance were observed after 5/6 nephrectomy, but they were
more severe in acatalasemic 5/6 nephrectomy mice com-
pared with wild-type 5/6 nephrectomy mice at the time
points later than 6 weeks (Fig. 1A and B). A significant
elevation of urinary albumin excretion was observed in
acatalasemic mice as compared to wild-type mice after
5/6 nephrectomy (Fig. 1C).
Acatalasemia accelerates periglomerular fibrosis
and increases expression of type I and type IV collagens
in tubulointerstitium of remnant kidneys
In wild-type and acatalasemic sham-operated mice, no
histologic abnormalities of the kidneys were observed
at the light microscopic level (Fig. 2A and B). In acata-
lasemic mice after 5/6 nephrectomy, tubulointerstitial fi-
brosis developed, especially in the periglomerular area
in the deep cortex rather than the superficial cortex, and
it significantly increased as compared with that in wild-
type mice throughout the experiment (Fig. 2C, D, and M).
To examine which ECM components increase in acata-
lasemic remnant kidneys, tubulointerstitial expression of
type I and type IV collagens was investigated by immuno-
histochemistry. In the acatalasemic group, tubulointersti-
tial type I and type IV collagens were elevated at 6 weeks
after 5/6 nephrectomy and were significantly higher than
those in the wild-type group at time points later than
6 weeks throughout the experiment (Fig. 2N and O). A
marked increase in de novo expression of type I colla-
gen was observed in the interstitial expansion of acata-
lasemic 5/6 nephrectomy as compared with wild-type 5/6
nephrectomy (Fig. 2E and F). Type IV collagen was nor-
mally expressed in the glomerular and tubular basement
membrane in both control kidneys (Fig. 2G and H). The
increase in type IV collagen was more prominent in the
acatalasemic remnant kidneys as compared to the wild-
type remnant kidneys at 18 weeks after 5/6 nephrectomy
(Fig. 2I and J). After 5/6 nephrectomy, kidney sections
from wild-type mice exhibited glomerular hypertrophy
and glomerular sclerosis (Table 3). In acatalasemic mice
after 5/6 nephrectomy, the degree of glomerular sclerosis
was more severe after 12 and 18 weeks as compared to
that in wild-type mice (Fig. 2K and L) (Table 3).
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Fig. 2. Renal histology and deposition of tubulointerstitial collagens in wild-type and acatalasemic mice. Light micrographs of wild-type (A) and
acatalasemic (B) sham-operated kidneys at 18 weeks, and wild-type (C) and acatalasemic (D) remnant kidneys at 18 weeks after 5/6 nephrectomy
(5/6Nx). Note periglomerular tubulointerstitial fibrosis is significant in acatalasemic remnant kidneys compared with wild-type. Sham-operated
kidneys are microscopically normal. Immunofluorescent micrographs of wild-type (E) and acatalasemic (F) remnant kidneys at 18 weeks stained
with type I collagen, wild-type (G), and acatalasemic (H) sham-operated kidneys, and wild-type (I) and acatalasemic (J) remnant kidneys at
18 weeks stained with type IV collagen. Note increased de novo expression of type I collagen in interstitium of acatalasemic remnant kidneys.
Tubulointerstitial type IV collagen is also accumulated in remnant kidneys of acatalasemic mice. Light micrographs of a glomerulus of wild-type (K)
or acatalasemic (L) remnant kidneys at 18 weeks after 5/6 nephrectomy. Note significant glomerulosclerosis with periglomerular fibrosis develops
in remnant kidneys of acatalasemic mice. Interstitial fibrosis score (M), type I collagen (N), and type IV collagen (O) deposition score of wild-type
() or acatalasemic () mice (panels A and B, Masson-trichrome stain; panels C, D, J, and K, Azan stain). Scale bars are 400 (panels A and B),
200 (panels C and D), 100 (panels E to J), and 60 lm (panels K and L). In panels M to O, each column consists of means ± SE (N = 7 to 10
animals/group). ∗P < 0.05; ∗∗P < 0.01 vs. wild-type 5/6 nephrectomy mice at the same time point; #P < 0.05; ##P < 0.01 vs. sham at 0 week in the
same group.
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Table 3. Glomerular injury in remnant kidney model
Group 0 week 6 weeks 12 weeks 18 weeks
Diameter of glomerulus lm
Wild-type 5/6 nephrectomy 95.4 ± 2.6 100.0 ± 3.5 114.5 ± 1.3c 124.2 ± 2.1b
Acatalasemic 5/6 nephrectomy 91.9 ± 3.0 106.1 ± 6.7 119.7 ± 3.6c 130.0 ± 3.0a
Sclerosis index (score)
Wild-type 5/6 nephrectomy 0.00 ± 0.00 0.17 ± 0.08 1.21 ± 0.26b 2.42 ± 0.17a
Acatalasemic 5/6 nephrectomy 0.00 ± 0.00 0.28 ± 0.04 1.62 ± 0.17a 2.80 ± 0.07a,d
Values are means ± SE of 8 to 10 animals in each group.
aP < 0.001; bP < 0.01; cP < 0.05 vs. 0 week in the same group; dP < 0.05 vs. wild-type 5/6 nephrectomy group at the same time point.
Acatalasemia sensitizes remnant kidneys to EMT via
up-regulation of fibrosis-related genes
A morphologic study has suggested that TECs are able
to acquire a myofibroblast phenotype and play an im-
portant role in the pathogenesis of renal fibrosis associ-
ated with 5/6 nephrectomy in rats [15]. Since we found
an increase in the deposition of tubulointerstitial colla-
gens in the acatalasemic remnant kidneys (Fig. 2), we
further investigated whether acatalasemia activates tubu-
lar EMT in mice and studied the expression of fibrosis-
related genes by electron microscopy and real-time PCR.
In acatalasemic mice after 5/6 nephrectomy, TECs con-
taining abundant actin microfilaments in their cytoplasm
were observed adjacent to the interstitial fibrosis area
(Fig. 3A and B). It was difficult to identify the segment
of renal tubules containing actin microfilaments by elec-
tron microscopy, because such tubules lose their normal
structural characteristics, including their cellular polarity,
microvilli, and tight junctions. The percentage of TEC
containing the actin bundles significantly increased in
acatalasemic 5/6 nephrectomy mice (8.6 ± 0.8%) as com-
pared with wild-type 5/6 nephrectomy mice at 18 weeks
(2.8 ± 0.5%) (P < 0.05 vs. acatalasemic 5/6 nephrectomy
mice). No cytoplasmic actin filaments were observed
in the TECs of the control acatalasemic or wild-type
kidney (data not shown). Immunohistochemical stain-
ing revealed that the expression of a-SMA protein in
acatalasemic remnant kidneys was observed mainly in
the interstitium (Fig. 3C) but also to some extent in TECs
(Fig. 3D). Tubular EMT is regulated by the coordinated
expression of a number of related genes. The kinetics of
this gene expression revealed an early increase in a-SMA,
a crucial marker for the transformation of cells to myofi-
broblasts, in acatalasemic mouse kidneys at 6 weeks after
5/6 nephrectomy (Fig. 3E). The gene expression of FSP-1,
originally identified as specific for the fibroblast lineage,
increased thereafter (Fig. 3F), suggesting differential reg-
ulation of the a-SMA and FSP-1 genes in renal fibroge-
nesis in acatalasemia. The gene expression of TGF-b1
and CTGF, key growth factors promoting tubular EMT
in vitro and in vivo, significantly increased in the acata-
lasemic mice kidneys as compared with wild-type kidneys
after 5/6 nephrectomy (Fig. 3G and H). The levels of gene
expression of these fibrosis-promoting molecules were
not significantly different between two sham-operated
controls.
Renal and urinary peroxidation products increase in
acatalasemia after 5/6 nephrectomy
We hypothesized that oxidative stress may be a fac-
tor in stimulating renal interstitial fibrosis in acatalasemic
mice after 5/6 nephrectomy. Increased oxidative stress is
known to damage to cellular macromolecules including
nuclear DNA and membrane lipids. The major content
of the cell membrane is lipid, and thus lipid peroxida-
tion in tissues could cause renal injury. We next exam-
ined whether acatalasemia influenced lipid peroxidation
products in the tubulointerstitial compartment of rem-
nant kidneys. There was a mild increase in 4-HNE anti-
body labeling of various patches in the expansion of the
interstitium in wild-type remnant kidneys as compared to
sham-operated kidneys (Fig. 4A, C, and E). More intense
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−→
Fig. 3. Ultrastructural evidence for the tubular epithelial to mesenchy-
mal transition (EMT), expression of a-smooth muscle actin (a-SMA)
protein in tubulointerstitium of acatalasemic remnant kidneys and ex-
pression of fibrosis-related genes after 5/6 nephrectomy (5/6Nx). Elec-
tron micrographs of tubular epithelial cells (TECs) demonstrating the
early stage of EMT in acatalasemic mice at 18 weeks after 5/6 nephrec-
tomy. (A) A TEC contains characteristic bundles of actin microfilaments
(arrowheads) on the basal side of the tubular epithelial peripheral cyto-
plasm, lying parallel to partially disrupted (∗) tubular basement mem-
branes. (B) Higher magnification of a bundle of actin microfilaments
(arrowheads) within the cytoplasm of a tubular epithelia cell. Immuno-
histochemical staining of a-SMA in tubulointerstitium of acatalasemic
mice at 18 weeks after 5/6 nephrectomy. (C) Significant staining is ob-
served in the interstitium of acatalasemic remnant kidneys. (D) Higher
magnification showing a-SMA–positive staining (arrowheads) on the
basal side of the tubular epithelial cytoplasm in some areas. The renal
mRNA expressions of a-SMA (E), fibroblast specific protein-1 (FSP-1)
(F), transforming growth factor-b1 (TGF-b1) (G), and connective tis-
sue growth factor (CTGF) (H) in wild-type () or acatalasemic () mice.
Note acatalasemia significantly induced mRNA expression of a-SMA
in remnant kidneys after 5/6 nephrectomy as compared to its mild in-
duction in wild-type (E). Expression of EMT-related FSP-1 mRNA and
profibrotic TGF-b1 and CTGF mRNA are moderately induced in acata-
lasemic 5/6 nephrectomy. The relative expression ratios for each mRNA
in relation to glyceraldehyde-3-phosphate dehydrogenase (GAPDH
mRNA were determined. Each column consists of means ± SE (N =
7 to 10 animals/group). ∗P < 0.05 vs. wild-type 5/6 nephrectomy mice
at the same time point; #P < 0.05; ##P < 0.01 vs. sham at 0 week in
the same group. TL is tubular lumen. Scale bars are 2 (panel A), 1 lm
(panel B), 100 lm (panel C), and 20 lm (panel D).
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Fig. 4. Renal and urinary peroxidation products in wild-type and acata-
lasemic mice. Immunohistochemistry of lipid peroxidation products in
renal tubulointerstitium in remnant kidneys of wild-type and acata-
lasemic mice. Light micrographs of staining of 4-hydroxy-2- nonenal
(4-HNE)-modified proteins in wild-type (A) and acatalasemic (B)
sham-operated kidneys, and wild-type (C) and acatalasemic (D) rem-
nant kidneys at 18 weeks. Deposits of lipid peroxidation products
are evident in interstitium and vessels (∗) of acatalasemic remnant
kidneys (D). Accumulation of 4-HNE-modified (E) and 4-hydroxy-
2-hexenal (4-HHE)-modified proteins (F) in kidneys is semiquanti-
fied in wild-type () and acatalasemic mice (). Urinary 8-hydroxy-
2′-deoxyguanosine (8-OHdG) excretion is markedly increased in
acatalasemic 5/6 nephrectomy (5/6Nx) mice at time points later than
12 weeks as compared to wild-type 5/6 nephrectomy mice. Scale bars
are 100 lm (panels A to D). In panels E to G, each column consists of
means ± SE (N = 7 to 10 animals/group). ∗P < 0.05; ∗∗P < 0.01 vs. wild
5/6 nephrectomy at the same time point; #P < 0.05; ##P < 0.01 vs. sham
at 0 week in the same group.
antibody binding was observed in the tubulointerstitium
of acatalasemic remnant kidneys at time points later than
6 weeks as compared to wild-type (Fig. 4D and E). Sham-
treated kidneys gave only a trace of antibody reaction
(Fig. 4A and B). 4-HHE staining peaked at 6 weeks after
5/6 nephrectomy and it remained high in the acatalasemic
remnant kidneys through 18 weeks (Fig. 4F). Serum
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malondialdehyde (MDA) levels detected by the TBARS
method slightly increased in acatalasemia 18 weeks after
5/6 nephrectomy, without a significant difference from
those of wild-type mice (data not shown). The extent of
DNA damage has been evaluated by examination of uri-
nary 8-OHdG excretion. In acatalasemic mice at time
points later than 6 weeks after 5/6 nephrectomy, the uri-
nary excretion of 8-OHdG was markedly higher than that
in wild-type mice (Fig. 4G).
No significant compensation of glutathione peroxidase or
SOD for catalase in acatalasemic remnant kidneys
The maintenance of tissue homeostasis requires an
appropriate balance between oxidants and antioxidants.
Two major antioxidant enzymes, catalase and glutathione
peroxidase, are physiologically involved in the detoxifi-
cation of H2O2 and thus protect tissues from oxidant-
mediated injury. Therefore we next examined whether
other antioxidant enzymes could compensate for cata-
lase in acatalasemic remnant kidneys. Renal catalase ac-
tivity from the acatalasemic mice exhibited a 4.6-fold
(P < 0.01) decrease compared with wild-type mice at
the start of the experiment, and remained low during
the experimental period (Fig. 5A). The renal catalase
activity in wild-type mice continued to decrease until
18 weeks following 5/6 nephrectomy. Since high cata-
lase levels are found in erythrocytes [8], we compared
the catalase activity between saline-perfused and unper-
fused kidneys after the removal of residual blood. The
catalase activity of the perfused kidney was 6.0 ± 0.2%
lower than that of the unperfused kidney [22]. To exam-
ine the effect of acatalasemia on other renal antioxidant
enzymes in remnant kidneys, we investigated the activity
of glutathione peroxidase (Fig. 5B) and SOD (Fig. 5C)
in wild-type or acatalasemic mice. The activity of glu-
tathione peroxidase showed a temporary decrease at 6
to 12 weeks after 5/6 nephrectomy; however, there was
not any compensatory up0regulation of glutathione per-
oxidase in acatalasemic remnant kidneys or significant
difference in glutathione peroxidase activities between
the two mice groups (Fig. 5B). The level of SOD activity
decreased during the development of renal failure and
there were no significant changes in the activity of this
enzyme between the two groups (Fig. 5C). Since SOD
catalyzes the conversion of superoxide anion radical to
H2O2 and O2, it is suggested that the level of production
of ROS mediated by SOD may be similar in the remnant
kidneys in the two groups of mice.
A membrane-permeable SOD mimetic, tempol, does not
prevent peroxidation or tubulointerstitial fibrosis in
catalase deficiency
Tempol has been reported to act as a SOD mimetic pro-
ducing antioxidative activity in various biologic systems
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Fig. 5. Renal content of anti-oxidant enzymes in remnant kidneys of
wild-type () and acatalasemic mice (). Time courses of catalase (A),
glutathione peroxidase (GPX) (B), and superoxide dismutase (SOD)
(C) activities. Each enzyme activity is expressed as nmol/s/mg protein.
Each column consists of means ± SE (N = 7 to 10 animals/group). ∗P <
0.05; ∗∗P < 0.01 vs. wild-type 5/6 nephrectomy (5/6Nx) mice at the same
time point; #P < 0.05; ##P < 0.01 vs. sham at 0 week in the same group.
[39]. It is capable of dismuting superoxide anion radical
to produce H2O2. We next investigated whether the SOD
mimetic could prevent oxidant tissue injury in remnant
kidneys (Table 4). Infusion of tempol significantly inhib-
ited the daily urinary albumin excretion, renal deposition
of HNE peroxidation products, and interstitial fibrosis in
the wild-type mice at 12 weeks after 5/6 nephrectomy.
However, the superoxide dismutation by tempol exacer-
bated albuminuria or oxidant-mediated renal fibrosis in
the acatalasemic mice after 5/6 nephrectomy (Table 4),
suggesting this SOD mimetic may not be utilized as an
antioxidant under excessive oxidative stress in the acata-
lasemic kidney.
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Table 4. Effect of tempol on remnant kidney model at 12 weeks
Group Vehicle Tempol
Urinary albumin to creatinine excretion ratio
Wild-type 5/6 nephrectomy 0.72 ± 0.12 0.44 ± 0.08a
Acatalasemic 5/6 nephrectomy 2.29 ± 0.70b 3.77 ± 0.49a,c
HNE staining score
Wild-type 5/6 nephrectomy 1.23 ± 0.21 1.00 ± 0.25a
Acatalasemic 5/6 nephrectomy 2.45 ± 0.32b 2.71 ± 0.18a,b
Interstitial fibrosis score
Wild-type 5/6 nephrectomy 1.98 ± 0.30 1.47 ± 0.08a
Acatalasemic 5/6 nephrectomy 2.81 ± 0.19b 3.48 ± 0.14a,b
Values are means ± SE of 8 to 10 animals in each group.
aP < 0.05 vs. vehicle-treated group; bP < 0.05; cP < 0.01 vs. wild-type 5/6
nephrectomy in the same treatment group.
DISCUSSION
In the present study, acatalasemic mice strains defi-
cient in catalase activity were used as the animal model.
These mice were found to be more susceptible to func-
tional and morphologic alterations in kidneys induced by
5/6 nephrectomy than wild-type mice. The level of albu-
minuria in the acatalasemic mice after 5/6 nephrectomy
was significantly higher than that in wild-type mice. Uri-
nary and renal peroxidation products increased in the
acatalasemic mice after 5/6 nephrectomy as compared to
wild-type mice. Interstitial fibrosis with an increased accu-
mulation of type I and type IV collagens was more promi-
nent in the acatalasemic than wild-type remnant kidneys.
The acceleration of tubular EMT, a key event in renal
fibrogenesis, was observed in acatalasemic mice after 5/6
nephrectomy in association with an elevation of EMT-
regulated genes. Renal catalase activity remained low
without compensatory up-regulation of glutathione per-
oxidase or SOD. Moreover, supplementation of tempol,
a membrane-permeable SOD mimetic, did not prevent
oxidant-mediated renal fibrosis in catalase deficiency.
Collectively, the data suggest that ROS, particularly hy-
droxyl radical in the reduction of catalase activity, may
be involved in the acceleration of EMT and renal fibro-
genesis found in acatalasemic disease conditions.
Tissue fibrosis is considered to be a final outcome
characteristic of chronic organ injury. The process of
organ fibrosis includes the production of cytokines and
chemokines, migration of inflammatory cells into the in-
flamed sites, activation of fibroblasts to produce ECM,
regeneration of damaged tissue via cell proliferation and
differentiation, and finally ECM remodeling [40]. Mature
TECs in the adult kidney undergo EMT, a phenotype con-
version that is fundamentally linked to the pathogenesis
of renal tubulointerstitial fibrosis. In the current study, we
have sought evidence of phenotypic alteration of TECs
in the remnant kidney model of acatalasemic mice (Fig.
3). De novo expression of actin fibers in the cytoplasm of
TECs adjacent to interstitial fibrosis (Fig. 3A and B) and
a remarkable up-regulation of a-SMA genes (Fig. 3C)
were observed in remnant kidneys of the acatalasemic
mice after 5/6 nephrectomy. In terms of the regulation of
EMT, TGF-b1 [18] and CTGF [19] are considered to play
profibrotic roles. BMP-7 [17, 20] and HGF [21] are can-
didate antifibrotic molecules which might reverse EMT.
Crucial roles for integrin-linked kinase, an intracellular
serine/threonine protein kinase that interacts with the cy-
toplasmic domains of the b integrins in the regulation of
cell shape change [41] and with Smad signaling proteins
[42] in mediating tubular EMT, have also been reported.
Interestingly, H2O2 inhibited the expression of c-met, a
receptor for HGF in mouse renal TECs [43]. Therefore,
the data reported here support a role for H2O2 and hy-
droxyl radical in the promotion of tubular EMT and renal
fibrosis by suppressing the HGF-c-met interaction. More-
over, a recent in vitro study suggests that H2O2 induces
a-SMA expression, fibronectin secretion, and decreased
E-cadherin expression in rat proximal TECs and that
it may thus play an important role in TGF-b1–induced
EMT [44]. We demonstrated the up-regulation of the
TGF-b1 and FSP-1 genes in remnant kidneys of acata-
lasemic mice after 5/6 nephrectomy (Fig. 3). Since the up-
regulation of TGF-b1 and FSP-1 is merely a reflection of
the myofibroblast-like phenotype, the possibility remains
that it is the activated fibroblast, rather than TECs un-
dergoing EMT, which serves as a source of TGF-b1 and
FSP-1. A recent report suggests that about 36% of new fi-
broblasts come from local EMT, about 14% to 15% from
the bone marrow, and the rest from local proliferation in
renal fibrogenesis [32].
There is a discrepancy between the early development
of the tubulointerstitial fibrosis in the kidney at 6 weeks
(Fig. 2) and the relatively late progression of glomeru-
losclerosis at 12 weeks (Table 3) in acatalasemic mice. The
distribution of catalase is largely in the proximal tubules
in the kidney, and less in the distal tubules, Henle’s loops,
and the collecting duct tubules or the glomeruli. The ex-
pression of catalase in mice is stronger in the proximal
tubules in the juxtamedullary cortex rather than in the
superficial cortex as detected by immunohistochemistry
[45]. This may partly explain the findings that tubuloin-
terstitial fibrosis is observed in a periglomerular pattern
and is prominent in the deep cortex in the acatalasemic
mice after 5/6 nephrectomy. It is speculated that glomeru-
losclerosis may develop in the late stage as a consequence
of the tubulointerstitial injury in acatalasemia.
A significant albuminuria was observed and was asso-
ciated with decline in renal function and with tubulointer-
stitial fibrosis in acatalasemic mice after 5/6 nephrectomy.
The capacity of oxidants to impair the glomerular filtra-
tion barrier and give rise to increased rates of urinary
albumin excretion has been reported [46]. When H2O2
was infused into the renal artery to achieve renal concen-
trations in the low micromolar range, it gave rise to an
explosive, 50-fold increase in urinary albumin excretion
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without a hemodynamic effect or ultrastructural abnor-
malities of the glomerular basement membrane [46]. The
renal proximal TECs activated by reabsorption of fil-
trated albumin are thought to play an important role
in the generation of ROS in kidney disease. Albumin
per se can generate intracellular ROS in proximal TECs,
which are responsible for the activation of certain redox-
sensitive transcription factors, including nuclear factor-
jB (NF-jB) [47] and signal transducers and activators
of transcription (STAT5) [48]. Since the localization of
catalase in the kidney is mainly in the proximal tubules
[45], an overexposure of albumin to proximal TECs may
induce an oxidant burst in the acatalasemic tubular cells,
which subsequently conduct differential gene expression
and phenotypic alteration, including cell differentiation.
The interaction of albumin with the endocytosis recep-
tors megalin and cubilin of the proximal TECs may lead
to the generation of intracellular ROS [49]. We investi-
gated the expression of megalin in acatalasemic tubules
after 5/6 nephrectomy by immunohistochemistry; how-
ever, the expression level was comparable to that seen in
the wild-type mice (data not shown). Absorbed albumin
is degraded by lysosomal enzymes such as cathepsin B
and L in TECs. The inability to degrade albumin in lyso-
somal disorders can result in the accumulation of albumin
in TECs and subsequent cell injury [50]. Taken together,
although we cannot rule out the possibility that tubu-
lointerstitial fibrosis in acatalasemic mice is a secondary
event, the albuminuria which developed in acatalasemic
mice after 5/6 nephrectomy could well induce excess ROS
in TECs, which would then lead to tubular injury.
Catalase and glutathione peroxidase are two major an-
tioxidant enzymes involved in the degradation of H2O2
into nontoxic water and oxygen. Glutathione peroxidase
constitutes as a high affinity and low capacity degrada-
tive system, whereas catalase represents in contrast a rel-
atively low affinity and high capacity system. Glutathione
peroxidase constitutes the first, and catalase the second
line of defense against the buildup of H2O2. The two
enzymes act in a complementary fashion to metabolize
H2O2 generated in the course of both normal metabolic
and disease processes in the kidney. We first speculated
that glutathione peroxidase or SOD might compensate
for the catalase deficiency in acatalasemic remnant kid-
neys; however, no compensatory up-regulation of glu-
tathione peroxidase or SOD were evident in remnant
kidney. The supplementation of a membrane-permeable
SOD mimetic tempol, utilized as an antioxidant, did not
prevent peroxidation or tubulointerstitial fibrosis in the
acatalasemic remnant kidneys (Table 4). Recent reports
have indicated that this SOD mimetic increases the for-
mation of H2O2 and the increased H2O2, thereby, coun-
teracts its biologic actions in renal medulla [51, 52]. Our
data suggest that tempol may not be utilized as an antioxi-
dant under excessive oxidative stress in the acatalasemia.
Tempol would be expected to be able to effectively re-
duce oxidative stress if the catalase activity is sufficient in
the tissue.
Hypertension has important influence on the progres-
sion of renal diseases and glomerulosclerosis. In the
present study, the blood pressure in the acatalasemic
mice increased slightly after 5/6 nephrectomy without
significant difference compared to baseline blood pres-
sure (Table 2). The renal ablation model has been well-
characterized in different rat strains. In contrast, mice
have generally been resistant to this model. The paper by
Kren and Hostetter [38] demonstrated that no significant
differences were noted in blood pressure, proteinuria,
or histopathology including glomerulosclerosis between
control mice and mice after 5/6 nephrectomy induced by
renal artery ligation in a C57BL/6 background. Subse-
quently, Ma and Fogo [53] reported that in 129/Sv mice
with two renin genes and higher plasma renin activity,
blood pressure increased significantly after 5/6 nephrec-
tomy. They also speculated that the superior effects of
renal artery ligation plus cautery may result from higher
blood pressure responses. The pole resection protocol
utilized in this study may result in lower blood pressure
than the ligation plus cautery protocol. Moreover, the
C3H/AnL background may not be susceptible to systemic
hypertension even if the mice are systemically acata-
lasemic. Direct infusion of H2O2 into the renal medulla
resulted in an increase in blood pressure [51]. A threefold
elevation of the renal medullary interstitial H2O2 level
(to approximately 600 nmol/L) was necessary to induce
hypertension. In the current study, the concentration of
H2O2 in the renal tubulointerstitium might not have been
sufficient to increase the blood pressure in acatalasemic
mice after 5/6 nephrectomy, although we did not check
the concentration of H2O2.
At present there are few reports on the long-term
health effects of functional catalase deficiency in humans.
A high incidence of diabetes mellitus and deleterious
changes in lipid and carbohydrate metabolism have re-
cently been reported in Hungarian patients with acata-
lasemia, suggesting that this inherited disorder may be
one of the risk factors for the development of diabetes
mellitus and atherosclerosis [54]. Catalase deficiency may
also predispose to cumulative oxidant damage in human
pancreatic beta cells. Indeed, a preliminary study sug-
gested that acatalasemic mice are more susceptible to
the hyperglycemia induced by diabetogenic compound
alloxan as compared to wild-type mice (unpublished ob-
servations). However, the effect of acatalasemia on the
progression of kidney disease has been poorly under-
stood, with no definitive reports of renal fibrosis in pa-
tients with acatalasemia in the literature. The findings
presented here should provide an important first step to-
ward obtaining the necessary mechanistic insights to en-
able treatment of such patients.
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CONCLUSION
Acatalasemia sensitizes remnant kidneys to albumin-
uria and tubulointerstitial fibrosis by excessive oxidative
stress and the promotion of tubular EMT. Suppression
or detoxification of ROS is put forward as a possible
means to reverse tubular EMT and the subsequent fi-
brosis of the kidney. Consequently, future work on the
elucidation and development of novel therapeutic strate-
gies, including the overexpression of catalase and specific
quenching of hydroxyl radical to inhibit ROS-mediated
EMT and subsequent renal fibrosis in acatalasemia, is
urgently required. Moreover, an in vitro study to eluci-
date whether cultured renal TECs acquire a mesenchy-
mal phenotype on exposure to H2O2 in association with
TGF-b and CTGF expression is required and remains to
be carried out.
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